PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.

Bondue, Benjamin;Sherer, Félicie;Van Simaeys, Gaetan;Doumont, Gilles;Goldman, Serge;et.al.
(2015) The Journal of Nuclear Medicine — Vol. 56, n° 1, p. 127-132 (2014)

Files

No attached file found for this publication.

Details

Authors
  • Bondue, Benjamin
    Author
  • Sherer, Félicie
    Author
  • Van Simaeys, Gaetan
    Author
  • Doumont, Gilles
    Author
  • Author
  • Author
  • Goldman, Serge
    Author
Show more
Abstract
Idiopathic pulmonary fibrosis is characterized by a progressive and irreversible respiratory failure. Validated noninvasive methods able to assess disease activity are essential for prognostic purposes as well as for the evaluation of emerging antifibrotic treatments.
Affiliations

Citations

Bondue, B., Sherer, F., Van Simaeys, G., Doumont, G., Egrise, D., Yakoub, Y., Huaux, F., Parmentier, M., Rorive, S., Sauvage, S., Lacroix, S., Vosters, O., De Vuyst, P., & Goldman, S. (2015). PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis. The Journal of Nuclear Medicine, 56(1), 127-132. https://doi.org/10.2967/jnumed.114.147421 (Original work published 2014)